PTC Therapeutics opens gene therapy manufacturing facility in Hopewell

Gabrielle Saulsbery//October 14, 2021

PTC Therapeutics Inc. will open a new gene therapy manufacturing facility in Hopewell on Oct. 14.

The facility has approximately 220,500 square feet of office, manufacturing and laboratory space, including technology equipped to handle process development and manufacturing of plasmids and adeno-associated virus vectors.

“We are committed to being an innovation-based company that brings the best therapies to patients with rare diseases,” said Chief Executive Officer Stuart Peltz in a prepared statement. “Gene therapy holds tremendous promise to treat intractable rare genetic disorders. We have built our capabilities to both perform gene therapy research and to manufacture these biological products.”

“We are proud to have such a talented team and state-of-the-art manufacturing facility here in Hopewell, N.J. that will help expedite bringing these therapies to patients,” Peltz said.

The Hopewell gene therapy manufacturing center complements the company’s existing operations at its global headquarters in South Plainfield.

The total number of New Jersey-based employees is now up to 625.

A ribbon-cutting ceremony was slated for 4 p.m.